Health News

WHO announces a global decrease in COVID-19 cases that are new

WHO announces a global decrease in COVID-19 cases that are new

The number of new COVID-19 cases continued to fall

UK starts trial of multivariant COVID-19 vaccine booster

UK starts trial of multivariant COVID-19 vaccine booster

A phase one trial of a multivariant COVID-19 vacci

US clinical specialists to decide on Pfizer COVID-19 supporters

US clinical specialists to decide on Pfizer COVID-19 supporters

US medical experts will be meeting on Friday to d

Health News

Vaccinated pregnant ladies pass significant degree of antibodies to infants: Study

Women who receive the mRNA COVID-19 vaccine during pregnancy pass high levels of antibodies to their babies, according to a study. The effectiveness of COVID-19 vaccines lies in their ability to trigger the production of the right antibodies, blood proteins capable of protecting individuals from infection, researchers said. Whether this protection could pass from mothers to

WHO announces a global decrease in COVID-19 cases that are new

The number of new COVID-19 cases continued to fall last week, with 3.6 million new cases reported globally, down from 4 million new infections the previous week, the World Health Organization said. Last week’s drop marked the first substantial decline for more than two months, with falling COVID-19 cases in every world region. In its

UK starts trial of multivariant COVID-19 vaccine booster

A phase one trial of a multivariant COVID-19 vaccine booster drug has got underway among participants aged over 60 in the UK. The trial, involving GRT-R910, has been launched by US pharmaceutical company Gritstone in collaboration with the University of Manchester and Manchester University NHS Foundation Trust. It will explore the potential of the drug

India govt will not accepting Pfizer, Moderna vaccines in the midst of nearby yield: Report

India’s government will not buy COVID-19 shots from Pfizer/BioNTech and Moderna, three government sources told Reuters, mainly because domestic output of more affordable and easier-to-store vaccines has jumped. That essentially means the globally popular vaccines, which their makers have pledged not to sell to private parties during the pandemic, will not be available for now in the

HealthCube and Karkinos Healthcare rolled out cancer screening camp for women in Chikkaballapur

Bangalore, 20th September 2021: HealthCube, a diagnostics solution provider with the vision of transforming healthcare through the delivery of point-of-care diagnostics, has set-up cancer screening camps in Chikkaballapur, Karnataka to test for early signs/symptoms of the four major cancers, breast, oral, cervical and colorectal. The screening across the 6 taluks will be in accordance with

Researchers move forward in the development of microbial fuel cells

A UCLA-led group of engineers and chemists have taken an important step in the creation of fuel cells made by microbial organisms which is a method that makes use of natural bacteria to pull electrons out of organic material within the water to create electrical currents. A research paper detailing the groundbreaking technology was published

US clinical specialists to decide on Pfizer COVID-19 supporters

US medical experts will be meeting on Friday to debate and vote on the controversial question of giving out booster doses of Pfizer’s COVID-19 vaccine to the general population. President Joe Biden’s administration announced in August a plan to roll out third shots to everyone, not just the immune compromised already able to receive them, starting

US OKs new use for Eli Lilly’s COVID-19 diagnosis

Alaska’s state epidemiologist says Alaska is experiencing “one of the sharpest surges” in COVID-19 in the country.Dr. Joe McLaughlin added that it’s not clear when the situation might stabilize. He says a lot will depend on vaccination rates and measures such as masking and distancing. Health officials says hospitals are stressed, with staffing and capacity

Scientists foster new device to assist with giving early warning of uncommon and unknown virus

McMaster University researchers have created a new tool that can help identify deadly bacteria pathogens and early warning signs of unknown viruses. This algorithm can be used to develop advanced probes that capture trace amounts of pathogens from a variety of situations such as the animal-to human transmission of infections like SARS-CoV-2, or monitor environmental